Get started
LS ARK GENOMIC REVOLUTION TRACKER ETPLS ARK GENOMIC REVOLUTION TRACKER ETPLS ARK GENOMIC REVOLUTION TRACKER ETP

LS ARK GENOMIC REVOLUTION TRACKER ETP

No trades
See on Supercharts
Overview
Analysis
Holdings News Ideas Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪656.20 K‬ EUR
Fund flows (1Y)
‪114.54 K‬ EUR
Dividend yield (indicated)
—
Discount/Premium to NAV
1.09%
Shares outstanding
‪385.48 K‬
Expense ratio
0.35%

About LS ARK GENOMIC REVOLUTION TRACKER ETP


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Leverage Shares
Home page
leverageshares.com
Inception date
Dec 14, 2021
Structure
Irish VCIC
Index tracked
No Underlying Index
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Leverage Shares Management Co. Ltd.
ISIN
XS2399368062
The objective of the LS ARKG Genomic Tracker ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the Reference Asset),

Classification


Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Vanilla
Geography
Global
Weighting scheme
Fixed
Selection criteria
Fixed

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of May 8, 2025
Exposure type
Bonds, Cash & Other
ETF
Bonds, Cash & Other100.00%
ETF100.00%
Cash−0.00%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows